Cancer News and Research

Latest Cancer News and Research

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled “POU5-F1 Expression in Human Mesenchymal Stem Cells” and the development of new technology related to generation of human induced pluripotent stem cells (iPS).

2 Dec 2009

University of Pittsburgh's McGowan Institute for Regenerative Medicine awarded IBM SUR grant

The University of Pittsburgh's McGowan Institute for Regenerative Medicine, which connects scientists who work on tissue engineering, cell therapies, artificial organs and biodevices, has been awarded a Shared University Research (SUR) Award from IBM ( IBM). The IBM SUR Award will provide IBM computer hardware, software and services to Pitt for its cutting-edge "in silico" biological research, which uses computer simulations to explore biological pathways and test therapeutic interventions.

2 Dec 2009

Women at high risk of developing breast cancer reluctant to take tamoxifen for prevention

Even when women at high-risk of breast cancer are well-informed about the risks and benefits of using the drug tamoxifen for prevention, only 6 percent said they were likely to take it.

2 Dec 2009

Senators consider women's insurance amendment, Medicare funding issues, with votes likely today

The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."

2 Dec 2009

Patient enrollment complete in Peregrine Pharmaceuticals' Cotara trial

Peregrine Pharmaceuticals, Inc. today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with relapsed glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara is a targeted monoclonal antibody linked to a radioisotope being developed as a potential new treatment for GBM.

2 Dec 2009

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.

2 Dec 2009

FDA approves revised clinical trial protocol for CytRx' arimoclomol

CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), following the U.S. Food and Drug Administration’s (FDA) acceptance of a revised clinical trial protocol.

2 Dec 2009

FDA grants Fast Track designation for AEterna Zentaris' perifosine

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the Company's PI3K/Akt pathway inhibitor compound, perifosine (KRX-0401), for the treatment of relapsed/refractory multiple myeloma.

2 Dec 2009

Genta to supply Ganite for new CF clinical trial

Genta Incorporated announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (CF) who may develop serious infections.

2 Dec 2009

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the successful completion of a Phase 1 clinical study of its intravesical drug-device convergence system designed to provide sustained-release of drug directly to the bladder.

2 Dec 2009

World’s first 1000 MHz ultra-high field NMR AVANCE spectrometer installed at CRMN, France

Bruker BioSpin has successfully completed the installation of the world’s first 1000 MHz ultra-high field NMR AVANCE™ spectrometer at the Centre de Resonance Magnétique Nucléaire à Très Hauts Champs (CRMN) in Lyon, France (a joint research unit of CNRS, Ecole Normale Supérieure de Lyon and Université Lyon 1).

2 Dec 2009

S*BIO to present data on its novel oral JAK2 inhibitor at The American Society of Hematology meeting

S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans.

2 Dec 2009

Protein marker may hold the key against pancreatic cancer

Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.

2 Dec 2009

Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA

Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.

2 Dec 2009

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Roche announced today that the United States Food & Drug Administration (FDA) approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative, in-vitro test for the simultaneous, direct detection of the human immunodeficiency virus (HIV-1 Group M RNA, HIV-1 Group O RNA , HIV-2 RNA), hepatitis C virus RNA and hepatitis B virus DNA in human plasma.

From Roche Sequencing and Life Science 2 Dec 2009

Integrated eating disorders center to be launched shortly

NewYork-Presbyterian Hospital, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, in affiliation with the New York State Psychiatric Institute, announced the creation of an integrated eating disorders center. Opening today is a key clinical component of this new center -- The Outlook at NewYork-Presbyterian Hospital/Westchester Division in White Plains.

2 Dec 2009

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

2 Dec 2009

RSNA: Dec. 2, 2009 briefing and presentations

A special press briefing will be held Wednesday, Dec. 2, at 10:45 a.m. CT (11:45 a.m. ET), featuring a panel of top experts who will discuss the recent U.S. Preventive Services Task Force (USPSTF) release of revised screening mammography guidelines. Many patients, breast cancer survivors, medical experts and government authorities dispute the guidelines as being without scientific evidence.

2 Dec 2009

New PBS documentary examines why people view happiness as an elusive goal

On the eve of a new year, as millions of Americans struggle to find more meaning in their lives, Vulcan Productions and NOVA/WGBH have teamed up with Harvard psychologist and best-selling author of Stumbling on Happiness, Professor Daniel Gilbert, to produce This Emotional Life. This three-part documentary premieres on PBS January 4-6, 2010 (at 9:00 p.m. check local listings) and examines why people find happiness to be such an elusive goal.

2 Dec 2009

Jiangsu Yanshen Biological Technology Stock suspends production of all products

Simcere Pharmaceutical Group ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that its subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen") has suspended production of all its products in order to conduct an internal inspection and improve its quality control systems.

2 Dec 2009

Cancer News and Research

Latest Cancer News and Research

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

University of Pittsburgh's McGowan Institute for Regenerative Medicine awarded IBM SUR grant

Women at high risk of developing breast cancer reluctant to take tamoxifen for prevention

Senators consider women's insurance amendment, Medicare funding issues, with votes likely today

Patient enrollment complete in Peregrine Pharmaceuticals' Cotara trial

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

FDA approves revised clinical trial protocol for CytRx' arimoclomol

FDA grants Fast Track designation for AEterna Zentaris' perifosine

Genta to supply Ganite for new CF clinical trial

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

World’s first 1000 MHz ultra-high field NMR AVANCE spectrometer installed at CRMN, France

S*BIO to present data on its novel oral JAK2 inhibitor at The American Society of Hematology meeting

Protein marker may hold the key against pancreatic cancer

Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Integrated eating disorders center to be launched shortly

New data demonstrating the strength of Novartis' hematology portfolio to be presented

RSNA: Dec. 2, 2009 briefing and presentations

New PBS documentary examines why people view happiness as an elusive goal

Jiangsu Yanshen Biological Technology Stock suspends production of all products

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cancer News and Research

Latest Cancer News and Research

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in